Fetal tachycardia: A role for amiodarone as first- or second-line therapy?

Summary Background Fetal tachycardias result in serious prenatal and postnatal morbidity and mortality. Intrauterine treatment can improve prognosis dramatically and the therapeutic protocol is well defined. Currently, amiodarone is used as third-line therapy and is reserved for refractory cases. Ai...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of cardiovascular diseases 2008-10, Vol.101 (10), p.619-627
Hauptverfasser:	Pézard, Philippe Georges, Boussion, Françoise, Sentilhes, Loïc, Lépinard, Catherine, Couvreur, Marie-Hélène, Victor, Jacques, Geslin, Philippe, Descamps, Philippe
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Amiodarone Amiodarone - therapeutic use Anti-Arrhythmia Agents - therapeutic use Atherosclerosis (general aspects, experimental research) Atrial flutter Biological and medical sciences Blood and lymphatic vessels Cardiac dysrhythmias Cardiology. Vascular system Cardiovascular Female Fetal Diseases - drug therapy Fetal tachycardia Fetus Flutter auriculaire Fœtus Heart Humans Internal Medicine Maternal-Fetal Exchange Medical sciences Pregnancy Retrospective Studies Supraventricular tachycardia Tachycardia, Supraventricular - drug therapy Tachycardie supraventriculaire Tachycardie ventriculaire Tachycardies fœtales Treatment Outcome Ventricular tachycardia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!